The evidence-led answer
NST verdict
The broad training options do not need reinventing, but the programme should fit the person. The cited reviews report improvements in strength and body composition in postmenopausal women; they do not establish one programme for everyone. Bone outcomes need a more careful reading. The high-impact trial used a structured, supervised programme, not self-directed jumps at home. The separate creatine trial had no non-exercising comparison group, so it cannot establish how much exercise slowed bone loss. This article is not a prescription for impact exercise or a substitute for osteoporosis or menopause care.
Do the training fundamentals change?
No. A pooled analysis of 101 randomised trials in nearly 5,700 postmenopausal women found that exercise training increases muscle mass and fat free mass and reduces fat mass, body fat percentage, waist circumference and visceral fat. Aerobic and combined training did most for fat; resistance and combined training did most for muscle. A separate pooled analysis of 12 resistance training trials in healthy postmenopausal women found large gains in upper and lower body strength and in aerobic fitness. In other words, a mostly untrained woman after menopause responds to progressive resistance training and cardio in the same direction as anyone else. Combined resistance plus aerobic training is the sensible default. The method does not need reinventing.
Why the stakes rise
Oestrogen has a protective effect on muscle and bone, and its decline during and after the menopausal transition accelerates the age related loss of both, while shifting body fat towards the abdomen. That does not call for a different kind of training; it makes the training that was always worthwhile harder to skip. The muscle and strength you build offset sarcopenia; the mechanical load you put through the skeleton is one of the few things that slows bone loss; and the metabolic effects of combined training help with the fat redistribution. The downside of doing nothing simply gets steeper.
What about bone specifically?
The small ACTLIFE trial reported an improvement at the lumbar spine but not a statistically significant total-hip change after a supervised programme in selected women with low bone density. That result should not be converted into instructions to copy the programme at home. The two-year Chilibeck trial compared creatine with placebo while both groups exercised. Without a non-exercising comparison, the decline in bone density in both groups cannot tell us what would have happened without exercise. These studies do not establish that all exercise can only slow, never improve, bone density, or that this programme prevents fractures.
What to actually do differently
Resistance and aerobic exercise are options discussed in the cited reviews, not a universal schedule or promise of results. Do not use joint comfort alone to decide whether a high-impact programme is appropriate, and do not treat the supervised trial as a home jumping routine. Protein advice here is drawn from broader ageing research, not a menopause-specific intake trial. The creatine study does not establish a treatment for osteoporosis. Discuss symptoms and any bone-health concerns with your clinician; this article does not decide who needs a scan.
What this means in practice
Keep the focus on a sustainable programme matched to your experience and health, rather than adding impact automatically because of menopause. If you have osteoporosis, a previous fragility fracture, or concerns about bone health, seek individual guidance from a clinician or physiotherapist before changing impact or loading. This is not a requirement that every reader obtain a bone scan before ordinary activity. Menopause care, assessment for bone-density testing, and treatment decisions belong with your clinician.
Practical meaning
Keep the focus on a sustainable programme matched to your experience and health, rather than adding impact automatically because of menopause. If you have osteoporosis, a previous fragility fracture, or concerns about bone health, seek individual guidance from a clinician or physiotherapist before changing impact or loading. This is not a requirement that every reader obtain a bone scan before ordinary activity. Menopause care, assessment for bone-density testing, and treatment decisions belong with your clinician.
Limitations and uncertainty
The body composition evidence is a large but heterogeneous pooled analysis (101 trials varying in mode, dose, duration and participant age); several strength effect sizes in the 12 trial resistance training review are very large, hinting at heterogeneity or small study effects, and its bone and anthropometric findings were inconsistent. The bone specific evidence is thin: one small RCT (n=54) in women with low bone density, stopped early at 13 months, using a demanding supervised high impact protocol; and a 2 year RCT (n=237) that was designed to test creatine, had no not exercising comparison group, and still showed bone density declining despite training. The menopausal symptom improvement was a secondary outcome in that one small trial, so it is low certainty. The protein emphasis is extrapolated from ageing research rather than menopause specific trials here. Hormone therapy and the medical management of menopause and osteoporosis are out of scope and require a doctor.
No product needed
This page is here to answer the question, not force a product.
Some research pages are deliberately product-free because adding a retailer link would not help the reader make a better decision. When a product is genuinely relevant, it appears after the evidence and is clearly labelled.